Intracerebroventricular administration of streptozotocin as an experimental approach to Alzheimer's disease

International Journal of Neuroscience

Volumn 124, Issue 12, 2014, Pages 944-946

  Kalafatakis, Konstantinos ^a   Zarros, Apostolos ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Alzheimer's disease (AD); Experimental model; Streptozotocin (STZ).

Indexed keywords

STREPTOZOCIN;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; IN VIVO STUDY; INSULIN RESISTANCE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; REPRODUCIBILITY; SIMULATION; ANIMAL; DISEASE MODEL; HUMAN; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84909952142     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2014.890934     Document Type: Article

References (17)

1. Li Y. Establishment of experimental models for Alzheimers disease research. Int J Neurosci 2013;123:823-31.
2. Wang X, Yu S, Hu JP, et al. Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-?B pathway. Int J Neurosci 2014; Epub ahead of print.
3. Zarros A, Liapi C, Galanopoulou P, et al. Effects of adultonset streptozotocin-induced diabetes on the rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)- andMg2+-ATPase: modulation by L-cysteine. Metab Brain Dis 2009;24:337-48.
4. Salkovic-Petrisic M, Knezovic A, Hoyer S, et al. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimers disease, about the therapeutic strategies in Alzheimers research. J Neural Transm 2013;120: 233-52.
5. Park SA. A common pathogenic mechanism linking type-2 diabetes and Alzheimers disease: evidence from animal models. J Clin Neurol 2011;7:10-8.
6. Ejaz Ahmed M, Khan MM, Javed H, et al. Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimers type. Neurochem Int 2013;62:492-501.
7. Correia SC, Santos RX, Santos MS, et al. Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimers disease. Curr Alzheimer Res 2013;10:406-19.
8. Mehla J, Pahuja M, Gupta YK. Streptozotocin-induced sporadic Alzheimers disease: selection of appropriate dose. J Alzheimers Dis 2013;33:17-21.
9. Park SJ, Kim YH, Lee Y, et al. Selection of appropriate reference genes for RT-qPCR analysis in a streptozotocin-induced Alzheimers disease model of cynomolgusmonkeys (Macaca fascicularis). PLoS One 2013;8:e56034.
10. Chen Y, Liang Z, Tian Z, et al. Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice. Mol Neurobiol 2014;49:547-62.
11. Chen Y, Tian Z, Liang Z, et al. Brain gene expression of a sporadic (icv-STZ mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimers disease. PLoS One 2012;7: e51432.
12. Gao C, Liu Y, Jiang Y, et al. Geniposide ameliorates learning memory deficits, reduces Tau phosphorylation, and decreases apoptosis via GSK3? pathway in streptozotocininduced Alzheimer rat model. Brain Pathol 2014; Epub ahead of print.
13. Sodhi RK, Singh N. All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimers type. Prog Neuropsychopharmacol Biol Psychiatry 2013;40:38-46.
14. Lee Y, Kim YH, Park SJ, et al. Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimers disease monkey model induced by intracerebroventricular injection of streptozotocin. J Alzheimers Dis 2014;38:251-67.
15. Heo JH, Lee SR, Lee ST, et al. Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys. J Alzheimers Dis 2011;25:517-23.
16. Grieb P, Kryczka T, Fiedorowicz M, et al. Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin. Acta Neurobiol Exp (Wars) 2004;64:481-9.
17. Braidy N, Munoz P, Palacios AG, et al. Recent rodent models for Alzheimers disease: clinical implications and basic research. J Neural Transm 2012;119:173-95.